| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |